Praluent Injection (Alirocumab) for Treating High Cholesterol and Cardiovascular Diseases

Praluent injections, containing the active ingredient Alirocumab, are used either alone, in combination with dietary changes, or sometimes with other medications to treat adults with familial hypercholesterolemia, a genetic disorder that makes it difficult for the body to remove cholesterol naturally. Praluent injections work by reducing the levels of low-density lipoprotein (LDL) cholesterol, also known as bad cholesterol, in the blood.

Additionally, Praluent injections can be used to treat adults with heart and cardiovascular diseases to reduce the risk of stroke, heart attacks, angina, and life-threatening cardiovascular conditions. Treatment with Praluent in this patient group aims to prevent the accumulation of fats on artery walls, a process known as atherosclerosis. This facilitates blood flow in the arteries and improves oxygen supply to the heart, brain, and other parts of the body.

Praluent injections work by inhibiting the production of harmful cholesterol in the body, thereby reducing the amount of cholesterol that can accumulate on artery walls. The accumulation of cholesterol along artery walls, known as atherosclerosis, leads to reduced blood flow, consequently reducing oxygen supply to the heart, brain, and other body parts.

Praluent Price

Price in Saudi Arabia:

  • 75 mg concentration: SAR 936 for one pre-filled pen.
  • 75 mg concentration: SAR 1873 for a package containing two pre-filled pens.
  • 150 mg concentration: SAR 1873 for a package containing two pre-filled pens.
  • 150 mg concentration: SAR 936 for one pre-filled pen.

Price in Egypt:

  • 75 mg concentration: EGP 7800 for a package containing two pre-filled pens.
  • 150 mg concentration: EGP 7800 for a package containing two pre-filled pens.

Price in Jordan:

  • 75 mg concentration: JOD 218 for a package containing two pre-filled pens.
  • 150 mg concentration: JOD 218 for a package containing two pre-filled pens.

Usage Instructions

  • The pen is for single use only and should be disposed of after use.
  • The medicine is administered subcutaneously and can be self-administered or with the assistance of a healthcare professional.
  • Unused pens should be stored at temperatures ranging from 2 to 8 degrees Celsius.
  • Do not shake the pen before use.
  • Do not freeze the pen or expose it to direct sunlight.

Additional Tips

  • Always consult your doctor or pharmacist regarding the correct injection technique and appropriate injection sites.
  • Read the package insert for Praluent injections for more information on proper and safe use.

برالوينت (أليروكوماب) ۷٥ و ۱٥۰ مجم محلول للحقن تحت الجلد

تُحدد الجرعة وفق حالة المريض، ومدى الإستجابة للعلاج، وفي الغالب تكون جرعة البداية تكون حقنة واحدة تركيز ۷٥ ملليجرام مرة واحدة كل أسبوعين. سوف يقوم الطبيب بقياس مستويات البروتين الدهني منخفض الكثافة (LDL) قبل كل مرة حقن. في بعض الأحيان يُمكن أن تزيد الجرعة إلى ۱٥۰ ملليجرام مرة واحد كل أسبوعين أو 300 ملليجرام مرة واحدة كل أربعة أسابيع.

قراءة/ تحميل النشرة الداخلية المرفقة مع حقن برالوينت باللغة العربية من الرابط هنا


Praluent solution for injection – information leaflet


Sanofi-Aventis. (Drug Classification: C10AX14)

  • Drug Class: Lipid Modifying Agents
  • Active Ingredient: Alirocumab